GlassScriptPhysician profile
Rula M Youssef
NPI 1871647297
$1,184.08
in general payments reported to CMS, 2019-2025
15 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.48 · 2020: $17.52 · 2021: $164 · 2022: $133 · 2023: $343 · 2024: $324 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $228.95 | 2021-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $104.67 | 2021-2025 | |
| Painteq LLC | $102.33 | 2023-2024 | Painteq |
| Lilly USA, LLC | $101.37 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $95.44 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $91.33 | 2022-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $88.71 | 2021-2024 | Veozah |
| Amgen INC. | $79.82 | 2021-2023 | Prolia, Evenity |
| Boston Scientific Corporation | $61.07 | 2023 | Wavewriter Alpha Prime 16 |
| Curonix LLC | $53.39 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $46.58 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Novartis Pharmaceuticals Corporation | $45.11 | 2021-2023 | |
| Nevro Corp. | $44.48 | 2019 | |
| Abbvie INC. | $23.31 | 2023 | Botox |
| Medtronic USA, INC. | $17.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rula Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.